Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Haemonetics Corporation (HAE) had Weighted-Average Shares Outstanding (Diluted) of 47.35M for the most recently reported fiscal year, ending 2026-03-31.
| Income Statement Financials | |
$1.33B |
|
$97.31M |
|
$546.44M |
|
$787.59M |
|
$1.18B |
|
$156.73M |
|
$-28.70M |
|
$128.03M |
|
$128.03M |
|
$97.31M |
|
$97.31M |
|
$97.31M |
|
$97.31M |
|
$156.73M |
|
$274.26M |
|
47.18M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
47.35M |
$2.06 |
|
$2.05 |
|
| Balance Sheet Financials | |
$834.88M |
|
$305.76M |
|
$1.56B |
|
$2.40B |
|
$282.60M |
|
$1.22B |
|
$1.32B |
|
$1.60B |
|
$796.32M |
|
$-307.70M |
|
$796.32M |
|
45.25M |
|
| Cash Flow Statement Financials | |
$293.22M |
|
$-179.55M |
|
$-178.46M |
|
$306.76M |
|
$245.44M |
|
$-61.32M |
|
$33.83M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.95 |
|
-- |
|
-- |
|
0.60 |
|
1.54 |
|
59.04% |
|
11.75% |
|
11.75% |
|
20.56% |
|
9.60% |
|
7.29% |
|
$261.82M |
|
-- |
|
-- |
|
-- |
|
0.56 |
|
1.78 |
|
6.15 |
|
59.33 |
|
12.22% |
|
-31.62% |
|
4.06% |
|
4.83% |
|
$17.60 |
|
$5.53 |
|
$6.19 |
|